Nirma Ltd has agreed to buy 75% of Glenmark Life Sciences Ltd for ₹5,651.5 crore in a deal that values the latter at ₹7,535.4 crore. Mint reported first on 15 August that the cement-to-detergent maker was the sole...
Novo Holdings closes $462 million acquisition of Paratek Pharmaceuticals
Novo Holdings, the controlling shareholder in drugmaker Novo Nordisk, said it had closed its acquisition of biopharmaceutical company Paratek Pharmaceuticals in a deal valued at $462 million. The acquisition of Paratek...
Philip Morris to consider stake sale in biggest pharma unit – WSJ
Marlboro maker Philip Morris International is considering selling a stake in Vectura, its biggest pharmaceutical unit, the Wall Street Journal reported on Tuesday. The tobacco company told the Journal that it was...
Cabinet clears Advent’s acquisition of Suven Pharma for Rs 9,589 crore
The Cabinet Committee on Economic Affairs headed by Prime Minister Narendra Modi on Wednesday approved the FDI proposal for foreign investment of up to Rs.9589 crore in Suven Pharmaceuticals Limited by private equity...
lndiaRF to acquire API, CRAMS business of Ind-Swift Labs
IndiaRF, the India-focused investment platform promoted by Piramal Enterprises and Bain Capital, will acquire the active pharmaceutical ingredients (API) and contract research and manufacturing services (CRAMS) business...
Blackstone among global funds in race for Sai Life
About half a dozen global funds, such as Blackstone, Carlyle, PAG, CVC Capital, BPEA EQT, Brookfield Asset Management and Apax Partners, have evinced interest in acquiring Hyderabad-based pharmaceutical company Sai Life...
Cipla to acquire South Africa-based Actor Pharma
Drug major Cipla on Monday said its unit has inked a pact to acquire South Africa-based Actor Pharma. Cipla South Africa, a wholly-owned subsidiary of the Mumbai-based drug major, has inked a binding term sheet with...
Permira to buy UK pharma services firm Ergomed for $886 mln
European private equity firm, Permira, has agreed to buy British biopharmaceutical services company Ergomed for about 703.1 million pounds ($886.40 million), the two firms said on Monday, in the latest UK healthcare...
Biocon acquires Eywa Pharma’s US-based plant for $7.7 million
Biotechnology major Biocon said its unit has acquired Eywa Pharma Inc’s oral solid dosage manufacturing facility in the US for $7.7 million (over Rs 63 crore). Biocon Generics Inc has acquired Eywa’s...
Amgen gets FTC’s go-ahead for $27.8 billion Horizon deal
The U.S. Federal Trade Commission (FTC) has allowed Amgen to continue its $27.8 billion acquisition of Horizon Therapeutics, while preventing the drugmaker from using anticompetitive tactics to extend the market...
Torrent in top gear to close out Cipla buyout, in talks with PEs, banks for funds
Torrent Pharma is cranking up its efforts to put together financing to buy out the promoter family of Cipla, said several people with knowledge of the matter, emerging as a key contender to conclude the largest pharma...
Torrent joins fray for Hamied family stake in Cipla, up against Blackstone and Baring PE
In what would be its boldest move as yet, Torrent Pharma has joined the fray to buy out the Hamied family, the promoters of Cipla – a company that is more than double (2.3x) its FY23 consolidated revenues, and 2.3 times...
